1.
Li Y, Hou J, Jiang H, Wang D, Fu W, Yuan Z, Chen Y, Zhou L. Polymorphisms of CYP2C19 gene are associated with the efficacy of thalidomide-based regimens in multiple myeloma. Haematologica 2007; 92(9):1246-1249; https://doi.org/10.3324/haematol.11319.